GS 441524 CAS NO. 1191237-69-0

GS 441524 CAS NO. 1191237-69-0

GS 441524 CAS NO. 1191237-69-0

GS 441524 CAS NO. 1191237-69-0

GS 441524 CAS NO. 1191237-69-0

GS-441524 is a potent antiviral drug primarily used in the treatment of feline infectious peritonitis (FIP) in cats, caused by the feline coronavirus. As the active metabolite of Remdesivir, GS-441524 works by inhibiting viral replication, offering an effective solution for combating FIP and potentially other viral infections in animals. This nucleoside analog helps to reduce viral load, alleviate symptoms, and improve overall animal health.

Available in high-quality formulations, GS-441524 is trusted by veterinarians worldwide for its safety and efficacy in managing viral infections in pets, making it an essential treatment in veterinary medicine.

Treatment of Feline Infectious Peritonitis (FIP)


GS-441524 is primarily used as an effective antiviral treatment for FIP, a life-threatening viral disease caused by the feline coronavirus. It helps reduce viral replication, alleviates symptoms, and improves survival rates in cats diagnosed with FIP.


Veterinary Antiviral Therapy


Beyond FIP, GS-441524 holds potential for treating other viral infections in animals, including those caused by coronaviruses or other RNA viruses. It can be utilized in veterinary clinics to manage a broader range of viral diseases affecting pets and livestock.


Research and Development for Human Antiviral Therapies


As the active metabolite of Remdesivir, GS-441524 is also a subject of study for its potential in treating human viral infections, such as COVID-19 and other coronaviruses. Its effectiveness in animal models has led to research into its application in human medicine.






 


High Purity Neurotensin Analogs and Exemestane Class Probes
Jul 06, 26
High Purity Neurotensin Analogs and Exemestane Class Probes
The pharmaceutical landscape is constantly evolving, with a significant focus on the development of highly specific ligands to decode complex biological systems. Within this context, the study of the exemestane class of research toolsspecifically high-purity peptide analogsplays a pivotal role in understanding receptor-mediated signaling. By utilizing precise molecular modifications, researchers can now probe the intricacies of the neurotensin system with unprecedented accuracy. Globally, the demand for specialized research probes has surged as medicinal chemistry shifts toward rational drug design. The ability to modulate binding affinity and selectivity between receptor subtypes is no longer a luxury but a necessity
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
Jul 03, 26
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
The landscape of biochemical analysis has been significantly transformed by the introduction of high-precision substrates, a field where the concept of exemestane 25 mg bodybuilding often appears in search queries despite the stark difference between clinical aromataze inhibitors and laboratory reagents. In the realm of pharmaceutical manufacturing and food science, the ability to quantify protease activity with absolute precision is paramount for maintaining product stability and quality. Understanding the mechanism of chromogenic substrates allows researchers to bridge the gap between raw biochemical data and commercial application.
Understanding the Therapeutic Role of exemestane drug class
Jul 01, 26
Understanding the Therapeutic Role of exemestane drug class
Understanding the Exemestane Drug Class and Its Therapeutic Role In the realm of endocrine therapy for breast cancer, identifying the correct exemestane drug class is critical for optimizing patient outcomes. Exemestane belongs to a specialized group of medications designed to inhibit the production of estrogen, which fuels the growth of hormone-receptor-positive breast cancers. Unlike earlier generations of hormone therapies, this class offers a more direct approach to enzymatic inhibition. By targeting the final step of estrogen synthesis, it provides a robust mechanism for managing postmenopausal oncology cases. Understanding the nuances of this pharmacological category allows researchers and clinicians to better navigate

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.